Sally Kelliny

About Sally Kelliny

Sally Kelliny, With an exceptional h-index of 4 and a recent h-index of 4 (since 2020), a distinguished researcher at Assiut University, specializes in the field of Pharmacology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Sporadic Alzheimer’s disease animal model using streptozotocin and APP/PS1 mice

Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia

A new approach to model sporadic Alzheimer’s disease by intracerebroventricular streptozotocin injection in APP/PS1 mice

A Novel Oral Edaravone Formulation Partially Alleviates Tau Pathology and Motor Deficits in an Animal Model of Frontotemporal Dementia

Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer’s Disease, in Serum and Tissue of Sprague Dawley Rats

Peripheral ProBDNF delivered by an AAV vector to the muscle triggers depression-like behaviours in mice

Preclinical study of the pharmacokinetics of p75ECD-Fc, a novel human recombinant protein for treatment of Alzheimer’s disease, in Sprague Dawley rats

Sally Kelliny Information

University

Position

Lecturer Assistant Faculty of Pharmacy

Citations(all)

37

Citations(since 2020)

37

Cited By

5

hIndex(all)

4

hIndex(since 2020)

4

i10Index(all)

1

i10Index(since 2020)

1

Email

University Profile Page

Google Scholar

Sally Kelliny Skills & Research Interests

Pharmacology

Top articles of Sally Kelliny

Sporadic Alzheimer’s disease animal model using streptozotocin and APP/PS1 mice

2023/1/1

Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

Metabolic Brain Disease

2022/8

Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia

Neurotoxicity Research

2021/12

A new approach to model sporadic Alzheimer’s disease by intracerebroventricular streptozotocin injection in APP/PS1 mice

Molecular Neurobiology

2021/8

A Novel Oral Edaravone Formulation Partially Alleviates Tau Pathology and Motor Deficits in an Animal Model of Frontotemporal Dementia

2021/3/16

Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer’s Disease, in Serum and Tissue of Sprague Dawley Rats

European Journal of Drug Metabolism and Pharmacokinetics

2021/3

Peripheral ProBDNF delivered by an AAV vector to the muscle triggers depression-like behaviours in mice

Neurotoxicity Research

2020/10

Preclinical study of the pharmacokinetics of p75ECD-Fc, a novel human recombinant protein for treatment of Alzheimer’s disease, in Sprague Dawley rats

Current Drug Metabolism

2020/3/1

See List of Professors in Sally Kelliny University(Assiut University)

Co-Authors

academic-engine